Kovo HealthTech Corporation provided revenue guidance for the year of 2022. In its initial 2022 Guidance, the Company is anticipating Pro Forma Revenues of CAD 15,000,000 (USD 12,000,000), a 30% increase in year-over-year organic growth excluding additional acquisitions in 2022.